What is the recommended dose of Epitalon?

- **Look for:** Nothing. Epitalon is not an approved drug and no validated pharmaceutical-grade formulation exists. There is no seal or certification that makes an unapproved investigational peptid...

Is Epitalon safe to take daily?

Epitalon is rated "Generally Safe" based on clinical evidence. Always consult your healthcare provider before starting any supplement.

LOADINGLoading your Pro surface...

Ingredient Research

Graded against 173,636 supplements + 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, NIH DSLD

Epitalon

MODERATE EVIDENCEAmino AcidLast updated

AVELOR SUMMARY

No human trials in the sense that word normally means. Epitalon, also written Epithalon or Epithalone, is a synthetic four amino acid peptide (Ala-Glu-Asp-Gly, AEDG) designed from the amino acid composition of Epithalamin, a bovine pineal gland extract (Araj 2025, PMID: 40141333). Across 25 years of publication, PubMed indexes exactly one study on Epitalon carrying a clinical trial publication type, a non-randomized ophthalmology study from the institute that invented the peptide (Khavinson 2002, PMID: 12195242). A PubMed search for Epitalon combined with randomized and double-blind returns zero records, and a ClinicalTrials.gov search for Epitalon, Epithalon or AEDG as an intervention returns zero registered trials of any phase. The widely circulated claim that Epitalon lengthens telomeres does have real experimental support, but it is cell culture: in normal human fibroblasts and mammary epithelial cells, 1 microgram per milliliter for 3 weeks raised telomerase activity 4-fold and 26-fold respectively and significantly extended telomere length (Al-Dulaimi 2025, PMID: 40908429). That same study found something the marketing never mentions, which is that in two breast cancer cell lines the peptide raised Alternative Lengthening of Telomeres activity 10-fold and 3-fold. The rodent longevity data that anchor the "geroprotector" story are weaker than the summaries suggest: in rats kept on a standard 12-hour light cycle, Epitalon did not change lifespan in females (Vinogradova 2007, PMID: 18856211) and "virtually did not change" mean lifespan in males (Vinogradova 2008, PMID: 19110597). The separate and much stronger human mortality evidence people cite belongs to Epithalamin, the bovine pineal extract, not to Epitalon the tetrapeptide, and the two are not interchangeable. There is no published short-term or long-term toxicology, no genotoxicity study, no carcinogenicity study and no human drug interaction study; the 2025 review that surveyed the entire literature states this safety information is missing, and names short-term and long-term toxicity, genotoxic activity, carcinogenic potential, and food-drug and drug-drug interactions as the studies still required before Epitalon could be approved as a new active pharmaceutical ingredient (Araj 2025). Epitalon is not an approved drug, it has been identified by a Belgian public health institute laboratory inside two illegal pharmaceutical preparations (Vanhee 2015, PMID: 25535022), and it is described in the current literature as available for research use only (Al-Dulaimi 2025). Avelor does not score Epitalon as a dietary ingredient. Our assessment: an unapproved investigational peptide with interesting cell-culture biology, an unresolved cancer-cell signal, and no human safety database.

WHAT IT DOES

Everything in this section is preclinical. It describes what cell culture, rodent and primate studies report. None of it is a validated mechanism in humans, and the 2025 review that surveyed the whole field concluded the mechanism of action "remains unclear" despite 25 years of work (Araj 2025, PMID: 40141333).

The proposed primary mechanism is epigenetic rather than receptor-mediated. Epitalon is small enough to enter the nucleus, and molecular modelling plus experimental work reports preferential binding to linker histones H1.3 and H1.6 at specific sequence sites that contact DNA, which is the proposed basis for its effects on gene transcription (Khavinson 2020, PMID: 32019204). In human gingival mesenchymal stem cells the peptide raised mRNA for the neurogenic markers Nestin, GAP43, beta Tubulin III and Doublecortin by 1.6 to 1.8-fold along with the corresponding proteins (Khavinson 2020).

The telomere branch of the mechanism is the one consumers hear about. In normal human cells the peptide upregulates hTERT mRNA and telomerase enzyme activity, and telomere length follows (Al-Dulaimi 2025, PMID: 40908429). In cancer cells the picture inverts: hTERT mRNA rises but telomerase enzyme activity does not, and telomere extension instead runs through ALT recombination. The authors' own proposed explanation is that histone H1 binding may trap proteins on DNA and trigger break-induced repair, and that cancer cells are more susceptible because they express less histone H1 to begin with. That is a hypothesis about a mechanism, offered by the investigators, not a resolved finding.

The pineal branch rests on melatonin. In old rhesus monkeys the peptide stimulated evening melatonin output and normalized cortisol rhythm (Goncharova 2001, PMID: 11550036), and work in cultured rat pinealocytes reports effects on the pCREB transcription factor and the AANAT enzyme, both tied to melatonin synthesis (Araj 2025).

Two practical facts get lost in the mechanism story. First, short peptides like Epitalon are unstable and degrade rapidly in vivo, and no stabilizing chemical modification of Epitalon has been evaluated (Araj 2025). Second, Epitalon has three asymmetric centers and therefore exists as eight stereoisomers, of which only the all-L form is the natural sequence; the pharmacology of the other seven has not been studied, which matters for any product whose synthesis and purity are unverified (Araj 2025).

OPTIMAL DOSAGE

Look for: Nothing. Epitalon is not an approved drug and no validated pharmaceutical-grade formulation exists. There is no seal or certification that makes an unapproved investigational peptide a sound purchase.
Regulatory reality: A Belgian public health institute laboratory identified Epitalon inside two illegal pharmaceutical preparations and published the LC-MS analytical method for detecting it (Vanhee 2015, PMID: 25535022). The 2025 cell biology literature describes it as available as a synthetic supplement for research use only (Al-Dulaimi 2025, PMID: 40908429). A ClinicalTrials.gov search for Epitalon, Epithalon or AEDG as an intervention returns zero registered trials.
Contamination risk is documented, not hypothetical: systematic impurity profiling of the ten most frequently encountered falsified peptide drugs on one European market, sourced from three suspected illegal internet pharmacies, found wide variation in drug amount per unit, purity ranging from 5% to 75% for cysteine-containing peptides, and contamination with the class one toxic elemental impurities arsenic and lead, with multiple samples up to ten times the ICH toxicity limit for parenteral drugs and all arsenic present in the more toxic inorganic form (UNCITED: the cited PMID did not support this claim and was removed; this statement is not currently sourced). That study does not report whether Epitalon was one of the ten peptides it profiled, so read it as evidence about the illegal internet peptide supply channel rather than about Epitalon specifically.
Red flags, all of which are common on these products: vials labeled "research chemical" or "not for human consumption"; reconstitution instructions written by the seller rather than a pharmacist; a certificate of analysis hosted by the seller with no independent laboratory named; marketing that cites Epithalamin mortality studies as if they were Epitalon studies; telomere-length or biological-age claims sourced to cell culture papers.
Purity and stereochemistry: the compound has eight possible stereoisomers and only the all-L sequence is the studied one; the pharmacology of the other seven is unstudied (Araj 2025, PMID: 40141333). Unverified synthesis means an unverified isomer profile.
Sterility: injectable and nasal products bought online are not made under enforceable pharmaceutical standards. Endotoxin load, sterility and actual content are unverified, and injection carries an infection risk that an oral supplement does not.
Athletes: we found no PubMed-indexed source establishing Epitalon's anti-doping classification, so we make no claim about it. Check the current WADA prohibited list yourself before any use, and assume an unregulated vial may contain substances not on its label.
These statements have not been evaluated by the Food and Drug Administration. This content is informational and is not medical advice.

Scan a supplement containing Epitalon

SAFETY PROFILE

No human drug interaction study of Epitalon has ever been conducted. The 2025 review lists food-drug and drug-drug interaction studies among the work that still needs to be done before Epitalon could be approved as a new active pharmaceutical ingredient (Araj 2025, PMID: 40141333). Every row below is inferred from preclinical data or from the absence of data. None of it is a characterized interaction profile.

Critical Interactions (Do Not Combine Without Medical Supervision)

Moderate Interactions (Monitor Closely)

Theoretical/Low-Risk Interactions

WHO SHOULD BE CAREFUL

RELATED RESEARCH

5-HTP5-HTP (5-hydroxytryptophan) is an amino acid naturally produced in the body from

Acetyl-L-CarnitineMeta-analysis of 21 double-blind RCTs found significant cognitive improvement in MCI and early Alzhe

L-ArginineMeta-analysis of 11 RCTs: arginine reduced systolic BP by 5.39 mmHg and diastolic by 2.66 mmHg at do

BCAAs / EAAs

Scan Your Epitalon Supplement Browse all ingredients

Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:

Not medical advice. Based on published clinical research and systematic reviews.

Discover More

Explore

Browse All 834 Ingredients Browse All 20 Conditions